Johnson & Johnson (NYSE:JNJ) enters bearish pattern, death cross, but strong dividends & strategic moves in dermatology provide long-term appeal.
Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise
Where Today's News Shapes Tomorrow
